Bavarian Nordic A/S (BVNRY) Projected to Post Quarterly Earnings on Wednesday

Bavarian Nordic A/S (OTCMKTS:BVNRY) is projected to issue its quarterly earnings data on Wednesday, March 5th. Analysts expect the company to announce earnings of $0.40 per share for the quarter.

Bavarian Nordic A/S Price Performance

Shares of Bavarian Nordic A/S stock opened at $8.01 on Wednesday. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 11.61 and a beta of 1.68. The firm’s 50-day moving average is $8.69 and its 200 day moving average is $10.04. Bavarian Nordic A/S has a 1 year low of $6.86 and a 1 year high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.